Cost-effectiveness of Ontario's pandemic vaccine program

Vaccine. 2011 May 17;29(22):3829; author reply 3830-1. doi: 10.1016/j.vaccine.2010.08.089. Epub 2010 Sep 8.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H1N1 Subtype / pathogenicity
  • Influenza Vaccines / administration & dosage*
  • Influenza Vaccines / economics*
  • Influenza Vaccines / immunology
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Models, Statistical
  • Ontario / epidemiology
  • Pandemics / prevention & control*

Substances

  • Influenza Vaccines